| Leptin Receptor |
|---|
| Gene Symbol | LEPR |
| Full Name | Leptin Receptor |
| Alias | OB-R, LEPR, CD295 |
| Chromosome | 1p31.3 |
| NCBI Gene ID | [3953](https://www.ncbi.nlm.nih.gov/gene/3953) |
| OMIM | [164380](https://www.omim.org/entry/164380) |
| Ensembl ID | ENSG00000116678 |
| UniProt ID | [P48471](https://www.uniprot.org/uniprot/P48471) |
The LEPR (Leptin Receptor) gene encodes a cytokine receptor family member that mediates the effects of leptin on energy homeostasis, metabolism, and neuroendocrine function. Located on chromosome 1p31.3 in humans, LEPR is expressed in multiple tissues including the hypothalamus, pituitary, liver, and immune cells. The leptin receptor is a critical bridge between peripheral energy stores and central nervous system regulation of feeding, metabolism, and cognitive function.
The discovery of LEPR and its ligand leptin established one of the most important hormonal axes in mammalian physiology. The leptin-LEPR signaling pathway has since been implicated in numerous aspects of brain function beyond energy balance, including synaptic plasticity, neuroprotection, and more recently, neurodegeneration.
- Chromosomal location: 1p31.3
- Genomic span: ~170 kb, 20 exons
- Promoter: Tissue-specific, regulated by nutritional status
LEPR produces multiple splice variants generating diverse isoforms:
| Isoform |
Structure |
Expression |
Signaling |
| Ob-Rb |
Full-length, long form |
Hypothalamus, brainstem |
Competent |
| Ob-Ra |
Short form |
Choroid plexus, liver |
Limited |
| Ob-Rc |
Short form |
Multiple tissues |
Limited |
| Ob-Re |
Soluble form |
Blood, CSF |
None |
| Ob-Rf |
Truncated |
Testis |
Limited |
The Ob-Rb (long form) is the signaling-competent isoform primarily expressed in the hypothalamus and other brain regions. It contains the full intracellular domain required for JAK-STAT signaling.
The leptin receptor is a single transmembrane receptor belonging to the class I cytokine receptor family (gp130 family):
Leptin Receptor Domain Structure:
├── Extracellular Domain (~800 aa)
│ ├── N-terminal signal peptide
│ ├── Cytokine receptor homology (CRH) domain (CNN motifs)
│ ├── Ig-like domain
│ ├── Fibronectin type III domain
│ └── Membrane-proximal domain
├── Transmembrane Domain (~40 aa)
│ └── Single alpha-helix
└── Intracellular Domain (~300 aa)
├── JAK2 binding motifs
├── STAT3 recruitment site
└── Multiple tyrosine phosphorylation sites
- CRH domain — contains the leptin binding site
- JAK2 docking site — box1 and box2 motifs for JAK2 association
- STAT3 activation site — YXXQ motif for STAT3 phosphorylation
- Multiple tyrosine residues — serve as docking sites for SH2-containing proteins
The major signaling cascade for LEPR:
flowchart LR
A["Leptin"] --> B["LEPR dimerization"]
B --> C["JAK2 autophosphorylation"]
C --> D["STAT3 phosphorylation"]
D --> E["STAT3 dimerization"]
E --> F["Nuclear translocation"]
F --> G["Gene transcription"]
- Leptin binding — induces LEPR homodimerization
- JAK2 activation — associated JAK2 kinases undergo autophosphorylation
- STAT3 phosphorylation — STAT3 binds phospho-tyrosine motifs, is phosphorylated
- Dimerization — p-STAT3 forms dimers
- Nuclear translocation — STAT3 dimers enter nucleus
- Gene transcription — regulates SOCS3, POMC, NPY, and other targets
- JAK2 can activate PI3K via IRS proteins
- Leads to Akt activation
- Promotes cell survival and metabolic effects
- Important for neuroprotective actions
- JAK2 activates Ras-MAPK cascade
- Involved in growth, differentiation
- Synaptic plasticity modulation
- LEPR signaling can activate AMPK
- Energy sensing function
- May mediate metabolic effects in brain
- Hypothalamus — highest expression in arcuate nucleus
- POMC neurons (anorexigenic)
- NPY/AgRP neurons (orexigenic)
- Ventromedial hypothalamus — energy balance integration
- Dorsal vagal complex — peripheral signal integration
- Choroid plexus — Ob-Ra for leptin transport into CSF
- Hippocampus — modulates synaptic plasticity and memory
- Cortex — lower but significant expression
- Liver — metabolic regulation
- Adipose tissue — autocrine/paracrine effects
- Immune cells — cytokine signaling
- Kidney, lung, heart — lower expression
LEPR mutations cause monogenic obesity:
- Recessive LEPR deficiency — severe early-onset obesity
- Dominant-negative mutations — partial dysfunction
- Common variants — contribute to polygenic BMI variation
- Leptin resistance — functional impairment in common obesity
LEPR signaling is impaired in AD and represents a therapeutic target:
- Reduced LEPR expression in AD hippocampus
- Impaired JAK-STAT signaling in AD brain
- Leptin resistance — similar to insulin resistance
- Amyloid-beta effects — Aβ reduces LEPR signaling
- Neuroprotection — leptin protects against Aβ toxicity
- Clinical trials — leptin analog therapy in early AD
LEPR dysfunction contributes to PD pathogenesis:
- Reduced LEPR in substantia nigra of PD patients
- Impaired dopaminergic signaling via LEPR
- Metabolic dysfunction — LEPR regulates mitochondrial function
- Therapeutic potential — leptin agonists under investigation
- Type 2 diabetes — LEPR variants affect metabolic risk
- Cardiovascular disease — LEPR affects blood pressure
- Immune dysfunction — LEPR modulates inflammation
| Approach |
Mechanism |
Status |
| Leptin analogs |
Bypass leptin resistance |
Clinical (rare obesity) |
| LEPR agonists |
Direct receptor activation |
Preclinical |
| JAK2 inhibitors |
Modulate excessive signaling |
Research |
| STAT3 modulators |
Fine-tune transcription |
Research |
- Metreleptin — FDA-approved for congenital leptin deficiency
- Combination therapy — LEPR + amyloid-targeting in AD
- Neuroprotective strategies — enhancing LEPR signaling
- Lepr−/− mice — severe obesity, infertility, shortened lifespan
- Ob/Ob mice — leptin-deficient, similar phenotype
- Brain-specific knockout — metabolic and cognitive phenotypes
- LEPR overexpression — protected against neurodegeneration
- Human LEPR mutations — knock-in models for obesity